Skip to content

twitter
linkedin
onxeo

SUBSCRIBE TO OUR NEWS

EN
FR

CONTACT

Onxeo designs and develops novel oncology drugs targeting tumor DNA repair functions.

COMPANY
SCIENCE
PRODUCTS
INVESTORS
NEWS & EVENTS

Site-map

Last updated on 10/02/2019

COMPANY
SCIENCE
PRODUCTS
INVESTORS
NEWS & EVENTS

> SITE MAP

> LEGAL NOTICES

COMPANY

COMPANY

Profile
Executive Committee
Board of Directors
Join us
Contact us

SCIENCE

SCIENCE

DNA Damage Response
platON™
Collaborations

PRODUCTS

PRODUCTS

Pipeline
AsiDNA™
OX401
belinostat / Beleodaq®

INVESTORS

INVESTORS

Regulated Information
Governance
Shareholder Resources
Investor Relations

NEWS AND EVENTS

NEWS & RELEASES

Press Releases
Events & Presentations
NewsLetters
Media

SUBSCRIBE TO
OUR NEWS

ONXEO SA

49, avenue du Général Martial Valin
75015 PARIS – FRANCE
+33 (0) 1 45 58 76 00

© Copyright 2019 Onxeo
Photos : Onxeo - Design : 1sur1.net

Copyright © 2020 Onxeo Theme: Flash by ThemeGrill. Proudly powered by WordPress